Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

INSYS Therapeutics Inc (NASDAQ:INSY)

14.13
Delayed Data
As of 3:59pm ET
 -0.08 / -0.56%
Today’s Change
8.70
Today|||52-Week Range
19.96
+53.59%
Year-to-Date
No recent news for INSYS Therapeutics Inc.

Today’s Trading

Previous close14.21
Today’s open14.25
Day’s range13.90 - 14.69
Volume723,027
Average volume (3 months)869,612
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-87.01%
Earnings growth (this year)-211.58%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)-26.76%
P/E ratioNM
Price/Sales2.82
Price/Book3.79

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc-0.29-6.79%
SGYPSynergy Pharmaceutic...-0.21-5.69%
CLLSCellectis SA-0.22-0.93%
AKAOAchaogen Inc-0.44-1.99%
Data as of 4:00pm ET, 05/26/2017

Financials

Next reporting dateAugust 15, 2017
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$242.3M
Annual profit (last year)$7.6M
Net profit margin3.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Saeed Motahari
Chief Financial &
Accounting Officer
Darryl S. Baker
Corporate headquarters
Chandler, Arizona

Forecasts